logo
Home  > Inhibitors/Agonists  > Cell Cycle  > PPAR  > 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione

AI08239

111025-46-8 | 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione

Packsize Purity Availability Price Discounted Price    Quantity
10mg 95% in stock $14.00 $10.00 -   +
50mg 95% in stock $25.00 $18.00 -   +
250mg 95% in stock $58.00 $40.00 -   +
1g 95% in stock $106.00 $75.00 -   +
5g 95% in stock $299.00 $209.00 -   +
10g 95% in stock $449.00 $315.00 -   +
25g 95% in stock $760.00 $532.00 -   +
100g 95% in stock $1,879.00 $1,316.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Request Bulk Quote
Description
Catalog Number: AI08239
Chemical Name: 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione
CAS Number: 111025-46-8
Molecular Formula: C19H20N2O3S
Molecular Weight: 356.4387
MDL Number: MFCD00865504
SMILES: CCc1ccc(nc1)CCOc1ccc(cc1)CC1SC(=O)NC1=O
NSC Number: 758876

 

Computed Properties
Complexity: 466  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 25  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 1  
XLogP3: 3.8  

 

 

Upstream Synthesis Route 
  • Pioglitazone is a versatile pharmaceutical compound that finds wide application in chemical synthesis, particularly in the formation of novel drug derivatives and analogs. Its unique chemical structure, characterized by a thiazolidinedione ring and a methylpyridinyl side chain, serves as a key building block in the creation of various drug molecules with potential therapeutic benefits.In the realm of medicinal chemistry, Pioglitazone serves as a valuable precursor for designing new drugs aimed at treating conditions such as diabetes, metabolic disorders, and inflammation. Through strategic chemical modifications and structural optimizations, researchers can harness the molecular scaffold of Pioglitazone to develop compounds with improved pharmacokinetic properties, enhanced biological activities, and reduced side effects.The versatility of Pioglitazone in chemical synthesis lies in its ability to undergo diverse transformation reactions, including oxidation, reduction, or substitution processes, leading to the generation of structurally diverse analogs with potential pharmaceutical relevance. By leveraging the core structure of Pioglitazone as a foundation, chemists can explore various synthetic routes to create novel drug candidates with optimized therapeutic profiles, paving the way for innovation in drug discovery and development.
Literature
FEATURED PRODUCTS